SSIAs (selective serotonin inverse agonists) are used to treat hallucinations and delusions associated with Parkinson's disease. They block certain receptors in the brain to help prevent hallucinations, but do not affect dopamine, unlike other types of antipsychotic medications.
Selective serotonin inverse agonists (SSIAs) are used to treat hallucinations and delusions from Parkinson's disease psychosis. It's not clear how they work, but it may be by targeting serotonin receptors in the brain, which helps to balance mood and reduce symptoms like hallucinations and delusions. These medications are typically available in oral forms. Pimavanserin (Nuplazid) is an example of an SSIA.
PIMAVANSERIN treats hallucinations and delusions in people with Parkinson disease. It works by balancing substances in your brain that help regulate mood, behaviors, and thoughts. It does not help with body movements or coordination. It belongs to a group of medications called antipsychotics.
Disclaimer: Popularity is based on total prescriptions for the brand and generic versions of each drug, regardless of the condition being treated. Some drugs are prescribed for multiple conditions.
Subscribe and save
Get prescription saving tips and more from GoodRx Health. Enter your email to sign up